INDICATION: QUZYTTIR is indicated for the treatment of acute urticaria in adults and children 6 months of age and older. Limitations of Use: QUZYTTIR is not recommended in pediatric patients <6 years of age with impaired renal or hepatic function.

Support and reimbursement options for QUZYTTIR

Actor portrayals of a female doctor in a lab coat with a stethoscope around her neck facing and smiling at a middle aged man with a grey beard Actor portrayals of a female doctor in a lab coat with a stethoscope around her neck facing and smiling at a middle aged man with a grey beard Actor portrayals.

Comprehensive support to help your patients access treatment

TerSera SupportSource logo

TerSera SupportSource offers:

  • Reimbursement support
  • Benefits investigations
  • Assistance in providing information regarding prior authorization (PA) requirements
  • Education for you and your patients about the appeals process if coverage is denied
  • Patient Assistance Program for eligible patients who establish financial need and do not have insurance coverage. Terms and conditions apply 
Icon of phone representative

Call TerSera SupportSource at 1-855-686-8725
Monday-Friday, 9:00 AM – 6:00 PM EST

Additional support for you and your practice

Icon of a circle with a cross in the middle and a finger pressing the circle

REQUEST SAMPLES

Request samples through the QUZYTTIR Sample Program to evaluate whether QUZYTTIR may be right for your appropriate patients.

Contact your QUZYTTIR Account Manager to request samples.

Icon of hand holding a prescription note

FEEL REASSURED

The QUZYTTIR Assurance Program helps address reimbursement concerns by providing a credit for your practice if your patient's qualified claim is denied.

Contact TerSera SupportSource to learn more.

Helpful resources for coding and reimbursement support

Hospital outpatient and ambulatory surgical centers:

Icon of a circle with a dollar sign in the center and two arrows surrounding it

Access the full Reimbursement Guide for help with billing, coding, ordering, and more.

Disclaimer

Third-party reimbursement is affected by many factors. The information and assistance provided by TerSera SupportSource are presented for informational purposes only. They do not constitute reimbursement or legal advice. TerSera SupportSource does not promise or guarantee coverage, levels of reimbursement, or payment. Similarly, all Current Procedural Terminology (CPT) and Healthcare Common Procedure Coding System (HCPCS) codes are supplied for informational purposes only and represent no statement, promise, or guarantee, expressed or implied, by TerSera or its third-party service providers that these codes will be appropriate or that reimbursement will be made. The fact that a drug, device, procedure, or service is assigned an HCPCS code and a payment rate does not imply coverage by the Medicare program, but indicates only how the product, procedure, or service may be paid if covered by the Medicare program. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. Accordingly, the information may not be current or comprehensive. TerSera and its third-party service providers strongly recommend you consult your payer for its most current coverage, reimbursement, and coding policies. TerSera and its third-party service providers make no representations or warranties, expressed or implied, as to the accuracy of the information provided. In no event shall the third-party service providers or TerSera, or their employees or agents, be liable for any damages resulting from or relating to any information provided by, or accessed to or through, TerSera SupportSource. All HCPs and other users of this information agree that they accept responsibility for the use of this program.

QUZYTTIR Co-pay Savings Program

Eligible, commercially insured patients may pay as little as $0 co-pay.*

QUZYTTIR co-pay card image - Quzyttir (cetirizine HCl Injection) - Pay as little as $0 for eligible, commercially insured patients.
  • *For eligible, commercially insured patients. Co-pay card is subject to an annual limit. Patients are not eligible if prescriptions are paid for by any state or other federally funded programs, including, but not limited to, Medicare or Medicaid, Medigap, VA, DOD, TRICARE, or where prohibited by law. Additional terms and conditions apply.
Icon of a handshake
Request a representative

Get more information about QUZYTTIR and resources available to support your patients.

×